Record Information |
---|
Version | 1.0 |
---|
Created at | 2021-06-22 17:27:09 UTC |
---|
Updated at | 2021-08-20 00:00:47 UTC |
---|
NP-MRD ID | NP0043878 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Galangin |
---|
Description | Norizalpinin, also known as teptochrysin or galangin, belongs to the class of organic compounds known as flavonols. Flavonols are compounds that contain a flavone (2-phenyl-1-benzopyran-4-one) backbone carrying a hydroxyl group at the 3-position. Thus, norizalpinin is considered to be a flavonoid. Norizalpinin is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Galangin is found in Acacia neovernicosa, Achyrocline satureioides, Adenostoma sparsifolium, Alnus sieboldiana, Alnus alnobetula, Alpinia conchigera, Apis mellifera, Callitris columellaris, Chrysanthemum morifolium, Citrus sinensis, Dennstaedtia scabra, Endosamara racemosa, Entada phaseoloides, Gaga kaulfussii, Glycyrrhiza uralensis, Hedychium spicatum, Heliotropium subulatum, Heliotropium taltalense, Lippia graveolens, Lychnophora ericoides, Muntingia calabura, Notholaena candida, Origanum akhadarense, Origanum boissieri, Origanum hypercifolium, Origanum micranthum, Origanum pampaninii, Origanum vulgare , Pinus morrisonicola, Populus alba, Populus balsamifera, Populus canadensis, Populus cathayana, Populus deltoides, Populus laurifolia, Populus simonii, Populus suaveolens, Populus trichocarpa, Scutellaria baicalensis, Taxus yunnanensis, Trichostema lanatum, Zingiber mioga , Zingiber officinale and Zuccagnia punctata. It was first documented in 2012 (PMID: 22908567). Based on a literature review a significant number of articles have been published on Norizalpinin (PMID: 27719955) (PMID: 22887049) (PMID: 22985747) (PMID: 23143152). |
---|
Structure | OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC=CC=C2)=C1 InChI=1S/C15H10O5/c16-9-6-10(17)12-11(7-9)20-15(14(19)13(12)18)8-4-2-1-3-5-8/h1-7,16-17,19H |
---|
Synonyms | Value | Source |
---|
3,5,7-Trihydroxy-2-phenyl-4H-benzopyran-4-one | ChEBI | 3,5,7-Trihydroxyflavone | ChEBI | 3,5,7-TriOH-flavone | ChEBI | Teptochrysin | ChEBI | 3,5,7-Trihydroxy-2-phenyl-4-benzopyrone | HMDB | 3,5,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one | HMDB | 3,5,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one, 9ci | HMDB | 3,5,7-Trihydroxy-2-phenyl-4H-chromen-4-one | HMDB | 3,5,7-Trihydroxy-flavone | HMDB | 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-phenyl- (9ci) | HMDB | 5,7-Dihydroxyflavonol | HMDB | Galangin | HMDB | Norizalpinin | ChEBI |
|
---|
Chemical Formula | C15H10O5 |
---|
Average Mass | 270.2369 Da |
---|
Monoisotopic Mass | 270.05282 Da |
---|
IUPAC Name | 3,5,7-trihydroxy-2-phenyl-4H-chromen-4-one |
---|
Traditional Name | galangin |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC=CC=C2)=C1 |
---|
InChI Identifier | InChI=1S/C15H10O5/c16-9-6-10(17)12-11(7-9)20-15(14(19)13(12)18)8-4-2-1-3-5-8/h1-7,16-17,19H |
---|
InChI Key | VCCRNZQBSJXYJD-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 150 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 250 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 175 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 225 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 125 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 25 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, Pyridine-d5, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as flavonols. Flavonols are compounds that contain a flavone (2-phenyl-1-benzopyran-4-one) backbone carrying a hydroxyl group at the 3-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Flavonoids |
---|
Sub Class | Flavones |
---|
Direct Parent | Flavonols |
---|
Alternative Parents | |
---|
Substituents | - 3-hydroxyflavone
- 3-hydroxyflavonoid
- 5-hydroxyflavonoid
- 7-hydroxyflavonoid
- Hydroxyflavonoid
- Chromone
- Benzopyran
- 1-benzopyran
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Pyranone
- Monocyclic benzene moiety
- Benzenoid
- Pyran
- Vinylogous acid
- Heteroaromatic compound
- Organoheterocyclic compound
- Oxacycle
- Polyol
- Organooxygen compound
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | |
---|
Predicted Properties | |
---|
General References | - Blunder M, Orthaber A, Bauer R, Bucar F, Kunert O: Efficient identification of flavones, flavanones and their glycosides in routine analysis via off-line combination of sensitive NMR and HPLC experiments. Food Chem. 2017 Mar 1;218:600-609. doi: 10.1016/j.foodchem.2016.09.077. Epub 2016 Sep 13. [PubMed:27719955 ]
- Zhang W, Tang B, Huang Q, Hua Z: Galangin inhibits tumor growth and metastasis of B16F10 melanoma. J Cell Biochem. 2013 Jan;114(1):152-61. doi: 10.1002/jcb.24312. [PubMed:22887049 ]
- Li K, Xing S, Wang M, Peng Y, Dong Y, Li X: Anticomplement and antimicrobial activities of flavonoids from Entada phaseoloides. Nat Prod Commun. 2012 Jul;7(7):867-71. [PubMed:22908567 ]
- Huh JE, Jung IT, Choi J, Baek YH, Lee JD, Park DS, Choi DY: The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-kappaB in collagen-induced arthritis and bone marrow-derived macrophages. Eur J Pharmacol. 2013 Jan 5;698(1-3):57-66. doi: 10.1016/j.ejphar.2012.08.013. Epub 2012 Sep 14. [PubMed:22985747 ]
- Li S, Wu C, Zhu L, Gao J, Fang J, Li D, Fu M, Liang R, Wang L, Cheng M, Yang H: By improving regional cortical blood flow, attenuating mitochondrial dysfunction and sequential apoptosis galangin acts as a potential neuroprotective agent after acute ischemic stroke. Molecules. 2012 Nov 9;17(11):13403-23. doi: 10.3390/molecules171113403. [PubMed:23143152 ]
|
---|